These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31406378)

  • 1. Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
    Durai V; Bagadia P; Granja JM; Satpathy AT; Kulkarni DH; Davidson JT; Wu R; Patel SJ; Iwata A; Liu TT; Huang X; Briseño CG; Grajales-Reyes GE; Wöhner M; Tagoh H; Kee BL; Newberry RD; Busslinger M; Chang HY; Murphy TL; Murphy KM
    Nat Immunol; 2019 Sep; 20(9):1161-1173. PubMed ID: 31406378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.
    Bagadia P; Huang X; Liu TT; Durai V; Grajales-Reyes GE; Nitschké M; Modrusan Z; Granja JM; Satpathy AT; Briseño CG; Gargaro M; Iwata A; Kim S; Chang HY; Shaw AS; Murphy TL; Murphy KM
    Nat Immunol; 2019 Sep; 20(9):1174-1185. PubMed ID: 31406377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anatomy of a superenhancer.
    Kim S; Liu TT; Ou F; Murphy TL; Murphy KM
    Adv Immunol; 2024; 163():51-96. PubMed ID: 39271259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical and functional interaction among Irf8 enhancers during dendritic cell differentiation.
    Yamasaki T; Nishiyama A; Kurogi N; Nishimura K; Nishida S; Kurotaki D; Ban T; Ramilowski JA; Ozato K; Toyoda A; Tamura T
    Cell Rep; 2024 Apr; 43(4):114107. PubMed ID: 38613785
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Liu TT; Ou F; Belk JA; Bagadia P; Anderson DA; Durai V; Yao W; Satpathy AT; Murphy TL; Murphy KM
    Genes Dev; 2023 Apr; 37(7-8):291-302. PubMed ID: 36990511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription Factor IRF8 Governs Enhancer Landscape Dynamics in Mononuclear Phagocyte Progenitors.
    Kurotaki D; Nakabayashi J; Nishiyama A; Sasaki H; Kawase W; Kaneko N; Ochiai K; Igarashi K; Ozato K; Suzuki Y; Tamura T
    Cell Rep; 2018 Mar; 22(10):2628-2641. PubMed ID: 29514092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A RUNX-CBFβ-driven enhancer directs the Irf8 dose-dependent lineage choice between DCs and monocytes.
    Murakami K; Sasaki H; Nishiyama A; Kurotaki D; Kawase W; Ban T; Nakabayashi J; Kanzaki S; Sekita Y; Nakajima H; Ozato K; Kimura T; Tamura T
    Nat Immunol; 2021 Mar; 22(3):301-311. PubMed ID: 33603226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic control of early dendritic cell lineage specification by the transcription factor IRF8 in mice.
    Kurotaki D; Kawase W; Sasaki H; Nakabayashi J; Nishiyama A; Morse HC; Ozato K; Suzuki Y; Tamura T
    Blood; 2019 Apr; 133(17):1803-1813. PubMed ID: 30796024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8.
    Anderson DA; Ou F; Kim S; Murphy TL; Murphy KM
    J Exp Med; 2022 Feb; 219(2):. PubMed ID: 34958351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB
    Elizondo DM; Brandy NZD; da Silva RLL; Haddock NL; Kacsinta AD; de Moura TR; Lipscomb MW
    Front Immunol; 2019; 10():173. PubMed ID: 30800127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lncRNA identifies
    Xu H; Li Z; Kuo CC; Götz K; Look T; de Toledo MAS; Seré K; Costa IG; Zenke M
    Elife; 2023 Mar; 12():. PubMed ID: 36916882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.
    Kim S; Bagadia P; Anderson DA; Liu TT; Huang X; Theisen DJ; O'Connor KW; Ohara RA; Iwata A; Murphy TL; Murphy KM
    Immunity; 2020 Oct; 53(4):759-774.e9. PubMed ID: 32795402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ablation of cDC2 development by triple mutations within the Zeb2 enhancer.
    Liu TT; Kim S; Desai P; Kim DH; Huang X; Ferris ST; Wu R; Ou F; Egawa T; Van Dyken SJ; Diamond MS; Johnson PF; Kubo M; Murphy TL; Murphy KM
    Nature; 2022 Jul; 607(7917):142-148. PubMed ID: 35732734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells.
    Sontag S; Förster M; Qin J; Wanek P; Mitzka S; Schüler HM; Koschmieder S; Rose-John S; Seré K; Zenke M
    Stem Cells; 2017 Apr; 35(4):898-908. PubMed ID: 28090699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively.
    Sichien D; Scott CL; Martens L; Vanderkerken M; Van Gassen S; Plantinga M; Joeris T; De Prijck S; Vanhoutte L; Vanheerswynghels M; Van Isterdael G; Toussaint W; Madeira FB; Vergote K; Agace WW; Clausen BE; Hammad H; Dalod M; Saeys Y; Lambrecht BN; Guilliams M
    Immunity; 2016 Sep; 45(3):626-640. PubMed ID: 27637148
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Theisen DJ; Ferris ST; Briseño CG; Kretzer N; Iwata A; Murphy KM; Murphy TL
    Cancer Immunol Res; 2019 Jan; 7(1):29-39. PubMed ID: 30482745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment.
    Schönheit J; Kuhl C; Gebhardt ML; Klett FF; Riemke P; Scheller M; Huang G; Naumann R; Leutz A; Stocking C; Priller J; Andrade-Navarro MA; Rosenbauer F
    Cell Rep; 2013 May; 3(5):1617-28. PubMed ID: 23623495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.
    Chauhan KS; Das A; Jaiswal H; Saha I; Kaushik M; Patel VK; Tailor P
    Cell Immunol; 2022 Jan; 371():104468. PubMed ID: 34968772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of the Irf8 +32-kb enhancer disrupts dendritic cell lineage segregation.
    Ou F; Liu TT; Desai P; Ferris ST; Kim S; Shen H; Ohara RA; Jo S; Chen J; Postoak JL; Du S; Diamond MS; Murphy TL; Murphy KM
    Nat Immunol; 2024 Nov; 25(11):2043-2056. PubMed ID: 39375550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation.
    Kurotaki D; Osato N; Nishiyama A; Yamamoto M; Ban T; Sato H; Nakabayashi J; Umehara M; Miyake N; Matsumoto N; Nakazawa M; Ozato K; Tamura T
    Blood; 2013 Mar; 121(10):1839-49. PubMed ID: 23319570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.